Stem Cell Authority, Ltd. (SCAL)
Preserves stem cells from newborn umbilical cord blood for potential future medical use.
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+0.0%
The outlook
SCAL is trading near its 52-week highs and above both its 50- and 200-day moving averages. The stock shows a bullish technical setup, though analyst coverage appears minimal and the company carries a trailing P/E of 0.0, suggesting it is not currently profitable. Trading at penny-stock prices with minimal volume, this remains a highly speculative position.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$194,170
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
0.0